BiotechSigns exists because PDUFA calendars, Form 4 filings, and clinical trial data were all public — and scattered across a dozen sources nobody had bothered to connect.
Richard Burke built these tools because he needed them. Not as a startup. Not with a pitch deck. Not after a Series A. He built them the way a retail trader with 40 years of IT experience and a functioning bullshit detector actually solves problems — by noticing that the data he needed existed, was public, and nobody had bothered to make it useful for people who don't have a Bloomberg terminal and a six-figure research budget.
That's the whole origin story. No pivot. No vision statement.
Richard is a Gen X IT consultant who has spent four decades in the trenches — back when "the cloud" was just a weather report and you actually had to know what you were doing to ship software. He's worked across the full stack of enterprise IT long enough to remember when "agile" wasn't a buzzword, it was just Tuesday. He has also, not metaphorically, dived with sharks for NASA. That one's real. Read it again if you need to.
His operating doctrine — what he calls Guerilla Rinzai — is what happens when you combine the no-resources discipline of guerilla warfare with the zero-ceremony directness of Rinzai Zen. No drift. No fluff. No six-week planning cycles for a three-hour fix. You see the problem, you solve the problem, you move.
The tools at Guerilla Finance Inc. exist because of that doctrine: built fast, built lean, and built to give retail traders the same data edge that institutional shops pay six figures a year for.
BiotechSigns is one of five tools built under the Guerilla Finance Inc. umbrella. Each came from the same place: Richard sitting at a screen, watching something happen, and thinking: there should be a tool for this. Then building it. Usually before lunch.
Guerilla Finance Inc. is the vehicle. The mission is simple: democratize the data for the people, delivered at a price point that doesn't require you to work at a hedge fund to afford it.